查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1830996

血浆治疗市场

Plasma Therapy Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

血浆疗法市场预计将从 2024 年的 5.4017 亿美元扩大到 2031 年的 13.0843 亿美元，2025 年至 2031 年的复合年增长率预计为 13.80%。

分析师的观点

血浆疗法市场分析突显了以下关键成长因素：骨科疾病盛行率不断上升，尤其是在老年人群体中；运动员关节和肌肉损伤的增加；以及对微创美容治疗的需求不断增长。此外，根据患者个别需求客製化血浆疗法的能力预计将在2022年至2030年期间引领市场新趋势。

血浆疗法，也称为富血小板血浆 (PRP) 疗法，是指使用康復患者的血浆来治疗各种疾病并促进癒合。 PRP 疗法在骨科中用于关节损伤，在皮肤科用于皮肤再生，在牙科用于组织修復。 PRP 中的生长因子可有效刺激组织再生，加速损伤癒合并增强美容效果。

市场洞察骨科疾病和肌肉损伤发病率的不断上升以及 PRP 在美容治疗中的应用日益广泛推动了血浆疗法市场的发展根据世界卫生组织 (WHO) 于 2023 年发布的资料，2019 年全球约有 5.28 亿人患有骨关节炎 (OA)，自 1990 年以来增长了 113%。 PubMed Central 2020 年 12 月的一篇文章指出，PRP 因其富含生长因子和细胞因子而具有巨大的组织修復潜力，这些生长因子和细胞因子对于创造和调节软组织和硬组织的再生环境至关重要。 PRP 疗法有助于骨折、韧带、肌肉和肌腱损伤、週边神经损伤、关节软骨病变和骨关节炎的癒合。因此，骨科和组织修復应用对血浆疗法的需求强劲。

此外，PRP 在美容手术中的应用日益广泛，包括皮肤再生、抗衰老和其他美容应用。 2021 年 11 月发表于 PubMed Central 的一篇综述评估了 73 项研究，其中 45 项研究了 PRP 单药治疗，35 项研究了 PRP 与微针疗法的联合应用。这些疗法通常耐受性良好，且对各种肤质均有效。据报道，PRP 在皮肤再生、疤痕修復、脱髮、色素沉着、硬化性苔藓、麻风病引起的周边神经病变、斑块状干癣和指甲疾病等疾病方面均取得了积极成果。

因此，PRP 在美容手术中的应用对血浆疗法市场的成长做出了重大贡献。

未来趋势血浆治疗市场中以患者为中心的治疗定制选项的出现定制血浆治疗涉及根据患者的医疗状况和基因特征定制治疗方案以满足患者的特定需求。这些客製化工作旨在透过调整抗体和蛋白质等成分的组成来提高血浆治疗的有效性，从而更好地解决患者的健康问题。研究人员和医疗保健专业人员正在努力针对自体免疫疾病、传染病和罕见癌症等特定疾病开发客製化的血浆疗法。 Regenexx 和 Bridging Biosciences 等公司提供高纯度和浓缩的 PRP，可以客製化以确保组织癒合和细胞再生的一致性。位于德州的美国医学研究所提供 PRP TruDose 疗法，可为各种慢性疼痛状况提供个人化治疗剂量，包括肌肉骨骼问题、红斑性狼疮、食物敏感性、莱姆病和其他退化性疾病。

策略性洞察报告细分和范围基于类型的洞察血浆疗法市场按类型分为纯PRP、富白血球PRP、纯富血小板纤维蛋白和富白血球纤维蛋白。纯富血小板纤维蛋白细分市场在2022年占据最大市场份额，预计在2022年至2030年期间将呈现最高复合年增长率。富白血球PRP (LR-PRP) 的中性粒细胞（白血球）浓度高于基线水平，通常与促发炎作用相关。然而，LR-PRP 也可能有助于刺激炎症，从而提示肌腱病等慢性疾病。

基于来源的洞察血浆治疗市场分为自体来源和异体来源，其中自体来源在 2020 年引领市场。

基于应用的洞察：按应用细分，血浆治疗市场可分为骨科疾病、皮肤科疾病、牙科疾病及其他疾病。 2022年，皮肤科疾病占了最大的市场。

基于终端用户的洞察：就终端用户而言，血浆治疗市场分为医院和诊所、研究机构、门诊手术中心 (ASC) 和其他。医院细分市场在 2022 年占据最大市场份额，预计在 2022 年至 2030 年期间将实现最高复合年增长率。

血浆治疗市场报告范围区域分析

2022年，北美引领血浆疗法市场，预计在2022年至2030年期间将创下最高复合年增长率。北美市场分为美国、加拿大和墨西哥，其中美国占据全球血浆疗法市场的最大份额。该地区的成长动力包括：骨科和美容手术中富血小板血浆 (PRP) 的日益普及、医疗保健领域投资的不断增加、充满活力的研发环境以及美国食品药物管理局 (FDA) 对部分 PRP 疗法的批准。

该报告介绍了全球血浆治疗市场的关键参与者，包括 BioLife Plasma Services、武田药品工业株式会社、Biotest AG CSL Ltd.、Grifols, SA、Kedrion SpA、ImmunoTek Bio Centers、Bio Products Laboratory Ltd.、中国生物製品控股公司、Octapharma AG 和 Origin, Inc.。这些领先公司专注于扩大和多样化其市场影响力和客户群，以利用现有的商业机会。

主要市场参与者的关键发展：2023 年 3 月，BioLife Plasma Services 宣布在西斯普林菲尔德（马萨诸塞州）和皮尔兰（德克萨斯州）开设新的血浆捐赠中心，以增强其业务网络。 2021 年 2 月，Atlas Health Medical Group 推出了 SkinPen，这是一种结合 PRP 进行脸部拉皮的微针设备，可刺穿皮肤以刺激抗衰老反应。 2020 年 3 月，武田药品工业株式会社开始开发抗 SARS-CoV-2 多克隆高免疫球蛋白 (H-Ig)，用于治疗重症 COVID-19 患者。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：血浆疗法市场格局

  • 概述
  • PEST分析

第五章：血浆疗法市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：血浆疗法市场－全球市场分析

  • 血浆疗法－全球市场概览
  • 血浆疗法－全球市场及2030年预测

第七章：血浆疗法市场-收入分析-按类型，2020-2030

  • 概述
  • 纯 PRP
  • 富含白血球的PRP
  • 纯富血小板纤维蛋白
  • 富含白血球的纤维蛋白

第 8 章：血浆疗法市场 - 收入分析 - 按来源，2020-2030 年

  • 概述
  • 自体
  • 同种异体

第九章：血浆疗法市场-收入分析-按应用，2020-2030

  • 概述
  • 骨科
  • 皮肤科
  • 心肌损伤
  • 牙科
  • 神经损伤
  • 其他的

第 10 章：血浆治疗市场 - 收入分析 - 按最终产品生产，2020-2030 年

  • 概述
  • 白蛋白
  • 免疫球蛋白G（IgG）
  • 其他的

第 11 章：血浆治疗市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院和诊所
  • 研究机构
  • 门诊手术中心

第 12 章：血浆疗法市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十三章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 14 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 15 章：血浆疗法市场 - 主要公司简介

  • BioLife Plasma Services
  • Takeda Pharmaceutical Company Limited
  • Biotest AG
  • CSL Ltd.
  • Grifols, S.A.
  • Kedrion S.p.A
  • ImmunoTek Bio Centers
  • Bio Products Laboratory Ltd.
  • China Biologic Products Holdings, Inc.
  • Octapharma AG
  • Origin, Inc.

第 16 章：附录

简介目录
Product Code: TIPRE00004429

The plasma therapy market is projected to expand from US$ 540.17 million in 2024 to US$ 1,308.43 million by 2031, with an estimated CAGR of 13.80% from 2025 to 2031.

Analyst's Perspective

The analysis of the plasma therapy market highlights key growth factors such as the increasing prevalence of orthopedic disorders, particularly among the elderly; a rise in joint and muscle injuries among athletes; and a growing demand for minimally invasive cosmetic treatments. Additionally, the ability to customize plasma therapies to meet individual patient needs is anticipated to create new trends in the market from 2022 to 2030.

Plasma therapy, also known as platelet-rich plasma (PRP) therapy, involves using blood plasma from individuals who have recovered from an illness to treat various medical conditions and promote healing. PRP treatments are utilized in orthopedics for joint injuries, in dermatology for skin rejuvenation, and in dentistry for tissue repair. The growth factors found in PRP effectively stimulate tissue regeneration, speeding up injury healing and enhancing aesthetic procedures.

Market Insights

Increasing Incidence of Orthopedic Disorders & Muscle Injuries and Growing Use of PRP in Aesthetic Treatments Drive Plasma Therapy MarketAccording to data from the World Health Organization (WHO) published in 2023, approximately 528 million people worldwide were living with osteoarthritis (OA) in 2019, marking a 113% increase since 1990. A December 2020 article in PubMed Central indicates that PRP has significant potential for tissue repair due to its rich content of growth factors and cytokines, which are essential for creating and regulating regenerative environments for both soft and hard tissues. PRP therapy can aid in the healing of bone fractures, ligament, muscle, and tendon injuries, peripheral nerve injuries, articular cartilage lesions, and osteoarthritis. Consequently, there is a strong demand for plasma therapies in orthopedic and tissue repair applications.

Furthermore, PRP is increasingly used in cosmetic procedures for skin rejuvenation, anti-aging, and other aesthetic applications. A review published in PubMed Central in November 2021 evaluated 73 studies, with 45 focusing on PRP monotherapy and 35 examining the effects of PRP combined with microneedling. The therapies were generally well-tolerated and effective across various skin types. Positive outcomes were reported for conditions such as skin rejuvenation, scar revision, alopecia, pigmentary disorders, lichen sclerosus, leprosy-induced peripheral neuropathy, plaque psoriasis, and nail disorders.

Thus, the application of PRP in cosmetic procedures significantly contributes to the growth of the plasma therapy market.

Future Trends

Emergence of Customization Options for Patient-Centric Therapies in the Plasma Therapy Market

Customized plasma therapy involves tailoring treatments to meet the specific needs of patients based on their medical conditions and genetic profiles. These customization efforts aim to enhance the effectiveness of plasma therapy by adjusting the composition of components like antibodies and proteins to better address the patient's health issues. Researchers and healthcare professionals are working to develop tailored plasma therapies for specific conditions such as autoimmune disorders, infectious diseases, and rare cancers. Companies like Regenexx and Bridging Biosciences offer highly pure and concentrated PRP that can be customized to ensure consistency in tissue healing and cell regeneration. The USA Medical Research Institute in Texas provides PRP TruDose therapy, which delivers personalized therapeutic doses for various chronic pain conditions, including musculoskeletal issues, LUPUS, food sensitivities, Lyme disease, and other degenerative diseases.

Strategic Insights

Report Segmentation and ScopeType-Based Insights

The plasma therapy market is categorized by type into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The pure platelet-rich fibrin segment held the largest market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030. Leukocyte-rich PRP (LR-PRP) contains a higher concentration of neutrophils (white blood cells) than the baseline level and is often associated with pro-inflammatory effects. However, LR-PRP can also be beneficial in stimulating inflammation to indicate chronic conditions like tendinopathy.

Source-Based Insights

The plasma therapy market is divided into autologous and allogeneic sources, with the autologous segment leading the market in 2020.

Application-Based Insights

By application, the plasma therapy market is segmented into orthopedic conditions, dermatology, dental issues, and others. The dermatology segment accounted for the largest market share in 2022.

End User-Based Insights

In terms of end users, the plasma therapy market is classified into hospitals and clinics, research institutes, ambulatory surgical centers (ASCs), and others. The hospital segment held the largest market share in 2022 and is projected to achieve the highest CAGR from 2022 to 2030.

Plasma Therapy Market Report Scope Regional Analysis

North America led the plasma therapy market in 2022 and is expected to record the highest CAGR during 2022 to 2030. The North American market is segmented into the US, Canada, and Mexico, with the US holding the largest share of the global plasma therapy market. The growth in this region is driven by the increasing adoption of platelet-rich plasma (PRP) in orthopedic and cosmetic surgeries, rising investments in healthcare, a dynamic research and development environment, and USFDA approvals for select PRP therapies.

The report profiles key players in the global plasma therapy market, including BioLife Plasma Services, Takeda Pharmaceutical Company Limited, Biotest AG CSL Ltd., Grifols, S.A., Kedrion S.p.A, ImmunoTek Bio Centers, Bio Products Laboratory Ltd., China Biologic Products Holdings, Inc., Octapharma AG, and Origin, Inc. These leading companies are focused on expanding and diversifying their market presence and client base to capitalize on existing business opportunities.

Key Developments by Major Market Players:In March 2023, BioLife Plasma Services announced the opening of new plasma donation centers in West Springfield (Massachusetts) and Pearland (Texas), enhancing its business network.In February 2021, Atlas Health Medical Group introduced the SkinPen, a microneedling device that incorporates PRP for facelifts, which punctures the skin to stimulate an anti-aging response.In March 2020, Takeda Pharmaceutical Company Limited began developing an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-Ig) to treat patients with severe COVID-19.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Plasma Therapy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Plasma Therapy Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Plasma Therapy Market - Global Market Analysis

  • 6.1 Plasma Therapy - Global Market Overview
  • 6.2 Plasma Therapy - Global Market and Forecast to 2030

7. Plasma Therapy Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Pure PRP
  • 7.3 Leukocyte-Rich PRP
  • 7.4 Pure Platelet-Rich Fibrin
  • 7.5 Leukocyte-Rich Fibrin

8. Plasma Therapy Market - Revenue Analysis (USD Million) - By Source, 2020-2030

  • 8.1 Overview
  • 8.2 Autologous
  • 8.3 Allogenic

9. Plasma Therapy Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 9.1 Overview
  • 9.2 Orthopedic
  • 9.3 Dermatology
  • 9.4 Cardiac Muscle Injury
  • 9.5 Dental
  • 9.6 Nerve Injury
  • 9.7 Others

10. Plasma Therapy Market - Revenue Analysis (USD Million) - By End Products Produce , 2020-2030

  • 10.1 Overview
  • 10.2 Albumin
  • 10.3 Immunoglobulin G (IgG)
  • 10.4 Others

11. Plasma Therapy Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 11.1 Overview
  • 11.2 Hospitals and Clinics
  • 11.3 Research Institutes
  • 11.4 Ambulatory Surgical Centers

12. Plasma Therapy Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Plasma Therapy Market Overview
    • 12.1.2 North America Plasma Therapy Market Revenue and Forecasts to 2030
    • 12.1.3 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Type
    • 12.1.4 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Source
    • 12.1.5 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Application
    • 12.1.6 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By End Products Produce
    • 12.1.7 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By End User
    • 12.1.8 North America Plasma Therapy Market Revenue and Forecasts and Analysis - By Countries
      • 12.1.8.1 United States Plasma Therapy Market
        • 12.1.8.1.1 United States Plasma Therapy Market, by Type
        • 12.1.8.1.2 United States Plasma Therapy Market, by Source
        • 12.1.8.1.3 United States Plasma Therapy Market, by Application
        • 12.1.8.1.4 United States Plasma Therapy Market, by End Products Produce
        • 12.1.8.1.5 United States Plasma Therapy Market, by End User
      • 12.1.8.2 Canada Plasma Therapy Market
        • 12.1.8.2.1 Canada Plasma Therapy Market, by Type
        • 12.1.8.2.2 Canada Plasma Therapy Market, by Source
        • 12.1.8.2.3 Canada Plasma Therapy Market, by Application
        • 12.1.8.2.4 Canada Plasma Therapy Market, by End Products Produce
        • 12.1.8.2.5 Canada Plasma Therapy Market, by End User
      • 12.1.8.3 Mexico Plasma Therapy Market
        • 12.1.8.3.1 Mexico Plasma Therapy Market, by Type
        • 12.1.8.3.2 Mexico Plasma Therapy Market, by Source
        • 12.1.8.3.3 Mexico Plasma Therapy Market, by Application
        • 12.1.8.3.4 Mexico Plasma Therapy Market, by End Products Produce
        • 12.1.8.3.5 Mexico Plasma Therapy Market, by End User
  • 12.2 Europe
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 Italy
    • 12.2.4 Spain
    • 12.2.5 United Kingdom
    • 12.2.6 Rest of Europe
  • 12.3 Asia-Pacific
    • 12.3.1 Australia
    • 12.3.2 China
    • 12.3.3 India
    • 12.3.4 Japan
    • 12.3.5 South Korea
    • 12.3.6 Rest of Asia-Pacific
  • 12.4 Middle East and Africa
    • 12.4.1 South Africa
    • 12.4.2 Saudi Arabia
    • 12.4.3 U.A.E
    • 12.4.4 Rest of Middle East and Africa
  • 12.5 South and Central America
    • 12.5.1 Brazil
    • 12.5.2 Argentina
    • 12.5.3 Rest of South and Central America

13. Industry Landscape

  • 13.1 Mergers and Acquisitions
  • 13.2 Agreements, Collaborations, Joint Ventures
  • 13.3 New Product Launches
  • 13.4 Expansions and Other Strategic Developments

14. Competitive Landscape

  • 14.1 Heat Map Analysis by Key Players
  • 14.2 Company Positioning and Concentration

15. Plasma Therapy Market - Key Company Profiles

  • 15.1 BioLife Plasma Services
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Takeda Pharmaceutical Company Limited
  • 15.3 Biotest AG
  • 15.4 CSL Ltd.
  • 15.5 Grifols, S.A.
  • 15.6 Kedrion S.p.A
  • 15.7 ImmunoTek Bio Centers
  • 15.8 Bio Products Laboratory Ltd.
  • 15.9 China Biologic Products Holdings, Inc.
  • 15.10 Octapharma AG
  • 15.11 Origin, Inc.

16. Appendix

  • 16.1 Glossary
  • 16.2 About The Insight Partners
  • 16.3 Market Intelligence Cloud